Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

E16: Tocilizumab in Giant-Cell Arteritis - GIACTA

E16: Tocilizumab in Giant-Cell Arteritis - GIACTA

FromThe Evidence Based Rheumatology Podcast


E16: Tocilizumab in Giant-Cell Arteritis - GIACTA

FromThe Evidence Based Rheumatology Podcast

ratings:
Length:
16 minutes
Released:
Apr 8, 2018
Format:
Podcast episode

Description

Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone.  It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.  
Released:
Apr 8, 2018
Format:
Podcast episode

Titles in the series (87)

A weekly podcast for physicians interested in evidence based medicine and rheumatology. Find the papers at ebrheum.com